-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Participants of the Advanced Training Program on National Pharmaceutical Inspection and Testing Technology and Biotechnology Visit Shijiazhuang Sihua Pharmaceutical Group for an Observation Tour
Category:
发布时间：2023-09-15
【概要描述】
Recently, the Advanced Training Program on “National Pharmaceutical Inspection and Testing Technologies and Biotechnology,” hosted by the Hebei Provincial Department of Human Resources and Social Security and organized by the Hebei Provincial Institute for Drug and Medical Device Testing, officially commenced. More than 100 professional technical personnel and senior managers holding mid- to high-level professional and technical titles from drug regulatory authorities, drug testing institutions, pharmaceutical manufacturing and R&D enterprises, hospital pharmacy departments, and pharmaceutical research institutes across the country are participating in this program.
Recently, the Advanced Training Program on “National Pharmaceutical Inspection and Testing Technologies and Biotechnology,” hosted by the Hebei Provincial Department of Human Resources and Social Security and organized by the Hebei Provincial Institute for Drug and Medical Device Testing, officially commenced. More than 100 professional and technical personnel holding mid- to senior-level professional titles, as well as senior managers, from drug regulatory authorities, drug testing institutions, pharmaceutical manufacturing and R&D enterprises, hospital pharmacy departments, and pharmaceutical research institutes across the country are participating in this program.
On September 14, during the field study component of the training program, the Provincial Medical Device and Pharmaceutical Testing Institute organized a visit to the R&D Center of Shijiazhuang Sihua Pharmaceutical Group, where participants engaged in observation and exchange activities centered on the theme “How to better support the high-quality development of the national pharmaceutical industry throughout the entire lifecycle of drugs.”
Sun Lijie, Group Executive President and General Manager of the R&D Center, together with relevant heads of the R&D Center, briefed the participants on the Group’s industrial development overview and showcased the research and innovation achievements attained in recent years. The participants then toured the Group’s R&D laboratories in several groups and engaged in lively discussions on topics such as research management and talent development, with all expressing that they had gained substantial insights and felt the visit had been well worth their while.
According to reports, this advanced training program will be held over five days. It has specially invited renowned domestic experts and scholars in the industry to deliver systematic coursework, conduct case studies and academic seminars, and organize on-site study tours. The curriculum covers such topics as the R&D and production development trends of generic drugs, common issues and key considerations in drug registration, critical inspection points and typical deficiencies in pharmaceutical manufacturing sites, the theory and practice of microbial-method suitability testing under the new GMP guidelines, as well as research on methods for authenticating traditional Chinese medicinal products and related case-sharing sessions. These activities are designed to help participants update their professional knowledge, explore new perspectives, enhance their technical skills, deepen their research and analysis of the industry, closely monitor developments in the pharmaceutical sector, strengthen efforts to advance pharmaceutical testing and biotechnology R&D, promote the deep integration of biopharmaceuticals with next-generation information technologies, and make significant contributions to the advancement of Healthy China.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091